Hagit Binder
Geschäftsführer bei NEUROSENSE THERAPEUTICS LTD.
Vermögen: 27 720 $ am 30.04.2024
Profil
Hagit Binder is currently the Chief Operating Officer at Neurosense Therapeutics Ltd.
Prior to this, she worked as the VP-Projects & Marketing at Nextar Chempharma Solutions Ltd.
from 2018 to 2022.
Ms. Binder completed her undergraduate, graduate, and MBA degrees at Bar-Ilan University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.04.2024 | 22 000 ( 0,13% ) | 27 720 $ | 30.04.2024 |
Aktive Positionen von Hagit Binder
Unternehmen | Position | Beginn |
---|---|---|
NEUROSENSE THERAPEUTICS LTD. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Hagit Binder
Unternehmen | Position | Ende |
---|---|---|
Nextar Chempharma Solutions Ltd.
Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that specializes in brain and central nervous system treatments. The private company is based in Ness Ziona, Israel. In addition to this, Nextar also serves as a contract development and manufacturing organization (CDMO) and has been involved in the development of over 120 innovative products. | Vertrieb & Marketing | 01.01.2022 |
Ausbildung von Hagit Binder
Bar-Ilan University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEUROSENSE THERAPEUTICS LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Nextar Chempharma Solutions Ltd.
Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Nextar Chempharma Solutions Ltd. is an Israeli biotechnology company that specializes in brain and central nervous system treatments. The private company is based in Ness Ziona, Israel. In addition to this, Nextar also serves as a contract development and manufacturing organization (CDMO) and has been involved in the development of over 120 innovative products. | Health Technology |